Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01763892 · ClinicalTrials.gov registry record
Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 60
- Enrollment target
NCT01763892: Completed study, sponsored by Duke University.
NCT01763892 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01763892 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The aims of this study explore the relationships between cerebral vasospasm, apolipoprotein-E (apo-E) genotype, physiologic symptoms, and neurocognitive outcomes that may either intensify or ameliorate secondary injury, for children with a traumatic brain injury. Exploring the apo-E genotype will help us know if injury response is altered in certain children and will aid in developing interventional approaches.
Primary Outcome
Collection of Apo-E allele will be obtained by buccal swab upon enrollment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-09 |
What the finished NCT01763892 record still lists
NCT01763892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01763892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01763892 about?
NCT01763892 is a clinical study titled "Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)". The aims of this study explore the relationships between cerebral vasospasm, apolipoprotein-E (apo-E) genotype, physiologic symptoms, and neurocognitive outcomes that may either intensify or ameliorate secondary injury, for children with a traumatic brain injury. Exploring the apo-E genotype will he...
What is the current status of trial NCT01763892?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-12. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01763892?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia